Merck Global Health Innovation Fund co-led the $5m equity portion of the series B round, while Silicon Valley Bank provided $3m in debt financing.

US-based healthcare IT services provider MedCPU closed an $8m series B round yesterday that included a $5m equity tranche co-led by pharmaceutical company Merck’s Global Health Innovation Fund.

Venture capital fund New Richmond Ventures co-led the equity tranche with Merck, while venture finance firm Silicon Valley Bank provided an additional $3m in debt financing.

Founded in 2009, MedCPU is the creator of a platform that analyses electronic medical records and matches them to data on best practices in order to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?